Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Ardea Biosciences reports results from combination trial of RDEA-594 and febuxostat

Dec. 3, 2009

Plethora Solutions and Columbia Laboratories execute marketing agreement for Striant SR

Dec. 3, 2009

Kalbitor approved in U.S. for hereditary angioedema

Dec. 3, 2009

Pfizer and Protalix to develop and commercialize taliglucerase alfa for Gaucher's disease

Dec. 2, 2009

CB1 receptor antagonists described by sanofi-aventis for the treatment of obesity

Dec. 1, 2009

Merck KGaA claims sodium-glucose transporter inhibitors as antidiabetics

Nov. 30, 2009

Merck & Co. to initiate phase IIa clinical trial of MK-6913 for vasomotor symptoms

Nov. 27, 2009

Genfit reports results from phase II trial of GFT-505 in fatty liver diseases

Nov. 27, 2009

Ohr presents update on clinical development of OHR/AVR-118 for cachexia

Nov. 27, 2009

Merck & Co. claims novel hypoxia-inducible factor prolyl hydroxylase inhibitors

Nov. 27, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...